Go back

Vet treatment trial uses nuclear medicine to detect canine cancer

The University of Queensland is using advanced cancer scanning technology to develop faster diagnosis and treatments for Australian veterinary practices.

The university recently conducted the country’s first dog PET-CT scans, to determine the cause of low blood sugar and seizures in a seven-year-old border collie in Brisbane.

The scans use a nuclear medicine imaging test known as positron emission tomography, in which a small amount of liquid radioactive material is injected into the body and used to diagnose cancers and conditions such as heart disease. The radioactive substance most commonly used in PET scanning is a sugar called FDG, which stands for fluorodeoxyglucose.

This article on Research Professional News is only available to Research Professional or Pivot-RP users.

Research Professional users can log in and view the article via this link

Pivot-RP users can log in and view the article via this link.